Prospective Evaluation of a Smartphone Application, GoCheckKids™, to Detect Amblyopia Risk Factors in Young Children

Sponsor
Gobiquity Mobile Health (Industry)
Overall Status
Completed
CT.gov ID
NCT03447171
Collaborator
(none)
207
1
3.8
53.9

Study Details

Study Description

Brief Summary

The objective is evaluation of GoCheck Kids, a smartphone application ('App'), for use as a photo screening device in a pediatric population to detect amblyopia risk factors (ARFs).

Condition or Disease Intervention/Treatment Phase
  • Device: App Vision Screening

Detailed Description

Detection of amblyopia risk factors using photo screening app in children of ages from 12 months to 8 years

Study Design

Study Type:
Observational
Actual Enrollment :
207 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Prospective Evaluation of a Smartphone Application, GoCheckKids™, to Detect Amblyopia Risk Factors in Young Children
Actual Study Start Date :
Feb 7, 2018
Actual Primary Completion Date :
Jun 4, 2018
Actual Study Completion Date :
Jun 4, 2018

Arms and Interventions

Arm Intervention/Treatment
Refractive Error

Device: App Vision Screening
Using GoCheck Kids App Vision Screening to detect Amblyopia Risk Factors

Outcome Measures

Primary Outcome Measures

  1. Sensitivity and specificity of amblyopia risk factors detected by Photorefraction [1 day]

    Identification of risk factors compared to gold standard cycloplegic refraction

Secondary Outcome Measures

  1. Number of patients with gaze error identified by photo screening [1 day]

    Detection of gaze error compared to cover test examination results

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Year to 8 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 12 months to 8 years inclusive.

  • Informed consent given by parent or legal guardian.

Exclusion Criteria:
  • History of ocular surgery and any condition that would preclude the ability of the investigator to obtain a reliable image and measurement

Contacts and Locations

Locations

Site City State Country Postal Code
1 Alaska Children's Eye & Strabismus Anchorage Alaska United States 99508

Sponsors and Collaborators

  • Gobiquity Mobile Health

Investigators

  • Principal Investigator: Sean Donahue, MD, PhD, Vanderbilt University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Gobiquity Mobile Health
ClinicalTrials.gov Identifier:
NCT03447171
Other Study ID Numbers:
  • 2018-001
First Posted:
Feb 27, 2018
Last Update Posted:
Aug 3, 2018
Last Verified:
Aug 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Gobiquity Mobile Health
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 3, 2018